CClinicalTrials.gg
Status unknownNCT03266341Updated Sep 1, 2017

Detection of Anaerobes in Different Clinicalsamples

An observational study in Anaerobic Bacterial Infection, sponsored by Assiut University. Status unknown. Per ClinicalTrials.gov, last updated 2017-09-01.

Sponsored by Assiut University · Observational

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Sex
All
01

Study summary

Early detection of anaerobic bacteria to avoid its serious comlications

Read the detailed description

Infections caused by anaerobic bacteria are common and may be serious and life-threatening.Obligately anaerobic bacteria do not grow on solid media in room air (0.04% carbon dioxide and 21% oxygen); facultatively anaerobic bacteria can grow in the presence or absence of air. Microaerophilic bacteria do not grow at all aerobically or grow poorly, but grow better under 10% carbon dioxide or anaerobically. Anaerobic bacteria can be divided into strict anaerobes that can not grow in the presence of more than 0.5% oxygen and moderate anaerobic bacteria that are able of growing between 2 and 8% oxygen. Anaerobic bacteria usually do not possess catalase, but some can generate superoxide dismutase which protects them from oxygen.

Anaerobes are the predominant components of the bacterial flora of normal human skin and mucous membranes, and are therefore a common cause of bacterial infections of endogenous origin. Infections due to anaerobic bacteria can evolve all body systems and sites . The predominant ones include: abdominal, pelvic, respiratory, and skin and soft tissues infections. Because of their fastidious nature, they are difficult to isolate from infectious sites and are often overlooked. Failure to direct therapy against these organisms often leads to clinical failures. Their isolation requires appropriate methods of collection, transportation, and cultivation of specimens. Treatment of anaerobic bacterial infection is complicated by the slow growth of these organisms, which makes diagnosis in the laboratory possible only after several days, by their often polymicrobial nature and by the growing resistance of anaerobic bacteria to antimicrobial agent.

Almost all anaerobic infections originate from the patient's own microflora. Poor blood supply and tissue necrosis lower the oxidation-reduction potential and favor the growth of anaerobes. Any condition that lowers the blood supply to an affected area can predispose to anaerobic infection. Therefore, foreign body, malignancy, surgery, edema, shock, traum and vascular disease may predispose to anaerobic infection. Previous infection with aerobic or facultative organisms also may make the local tissue conditions more favorable for the growth of anaerobic organisms. The human defense mechanisms also may be impaired by anaerobic conditions .

02

Conditions studied

  • Anaerobic Bacterial Infection

Browse trials for

03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Take different samples for dtection of the causitive anaerobe

Inclusion criteria

  • Patient with infection organism not yet detected

Exclusion criteria

Exclusion Criteria:

  • patients with infection organism is already detected
04

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • Diagnostic testCultures

    Take different samples anddetection of anaerobes on enriched blood agar and other selective anaerobic cultures

05

What researchers measure

Primary outcomes

  1. Detection of anaerobes in different clinical samples

    Samples will be in oculated on different anaerobic media

    Time frame: 2years

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT03266341
Lead sponsor
Assiut University
Responsible party
Safaa Samir (Detection of anaerobes in different clinical samples, Assiut University) — Principal investigator
First posted
Aug 30, 2017
Start date
Sep 15, 2017 (estimated)
Primary completion
Nov 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Sep 1, 2017

Study contacts

Safaa Ali samir hussien mohamed, Master
Contact
Safaa.samir191@gmail.com
01018612254
Sohair Mohamed ahmed, Proffisor
study director · Proffisor
Asmaa Omar ahmef, Assistant prof
principal investigator · Assistant pro

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion